Details of the Drug

General Information of Drug (ID: DMDY117)

Drug Name

ABBV-011

Indication

Disease Entry	ICD 11	Status	REF
Small-cell lung cancer	2C25.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody drug conjugate

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03639194) A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer. U.S. National Institutes of Health.